abstract |
The present invention relates to kinase inhibitors, particularly inhibitors of SIK kinase, more particularly SIK1, SIK2 and / or SIK3 and / or variants thereof, for use in the diagnosis, prevention and / or treatment of SIK-kinase related diseases, ≪ RTI ID = 0.0 > and / or < / RTI > Moreover, the present invention provides a method for using the compound as, for example, a drug or diagnostic agent. |